DIN 02244673 — TRILEPTAL ORAL SUSPENSION 60 MG
TRILEPTAL ORAL SUSPENSION is a suspension of Oxcarbazepine marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Oxcarbazepine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02244673
- Brand name
- TRILEPTAL ORAL SUSPENSION
- Active ingredient
- Oxcarbazepine
- Strength
- 60 MG
- Dosage form
- SUSPENSION
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antiepileptic (dibenzazepine derivative)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Oxcarbazepine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02284294 | APO-OXCARBAZEPINE | 150 MG | TABLET | APOTEX INC | MARKETED |
| 02284308 | APO-OXCARBAZEPINE | 300 MG | TABLET | APOTEX INC | MARKETED |
| 02284316 | APO-OXCARBAZEPINE | 600 MG | TABLET | APOTEX INC | MARKETED |
| 02560593 | JAMP OXCARBAZEPINE | 150 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02560607 | JAMP OXCARBAZEPINE | 300 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02560615 | JAMP OXCARBAZEPINE | 600 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02242068 | TRILEPTAL 300 MG | 300 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |
| 02242069 | TRILEPTAL 600 MG | 600 MG | TABLET | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |